ChiCTR-INR-16010047
结束
/
/
/
2016-11-25
/
/
鼻鼽(過敏性鼻炎症狀)
針刺聯合穴位敷貼治療鼻鼽(過敏性鼻炎症狀)的隨機對照臨床試驗
針刺聯合穴位敷貼治療鼻鼽(過敏性鼻炎症狀)的隨機對照臨床試驗
To determine the clinical effectiveness of either acupuncture combined with herbal moxibustion or acupuncture alone when compared to waiting list for patients with allergic rhinitis symptoms, measured by the improvement of nasal condition, quality of life, and serum IgE level.
随机平行对照
治疗新技术
Randomized
Single-blind on Investigator/research team
NA
/
48;0
/
1990-01-01
1990-01-01
/
1. Medical history: the subject has a history of allergic rhinitis, which is related to change in temperature and allergens such as pollen, dust mites, etc; 2. Clinical symptoms: the subject has the primary symptoms of nasal congestion, runny nose, sneezing and nasal itchiness. Subjects must have two or more of these symptoms; 3. Aged between 18 - 65; 4. A Total Nasal Symptom Score (TNSS) ≥ 4; 5. The subject agrees to take part in this study and is fully capacitated, can express personal will and accurately describe symptoms.;
请登录查看1. Has undertaken Chinese medicine treatment related to allergic rhinitis over the past month; 2. Has contracted respiratory infection or acute paranasal sinusitis within the past 14 days; 3. Has a history of chronic paranasal sinusitis; 4. Has organic nasal pathological changes or has had nasal surgeries; 5. Has asthma and other respiratory attack conditions; 6. Has taken antihistamines, steroids, decongestants (used on the nose, the mouth and the eyes), antibiotics, anti-coagulant and anti-platelet agents in the past month; 7. Has undertaken specific immune treatment or systemic hormone therapy in the past year; 8. Has serious cardiac, liver, renal, cerebrovascular conditions, or neural or mental disorders, etc.; 9. Be pregnant or nursing, or planning to conceive during the course of treatment; 10. Has G6PD; 11. Has wounds at the punctured locations or diabetes mellitus.;
请登录查看Department of Chinese Medicine, Hospital Authority
/
Department of Chinese Medicine, Hospital Authority的其他临床试验
Nethersole Chinese Medicine Service cum The Chinese University of Hong Kong Chinese Medicine Clinical Training and Research Centre的其他临床试验
最新临床资讯
-
飞眸医疗首例人体临床试验(FIH)成功开展,国产飞秒屈光设备竞逐540亿屈光市场
动脉网-最新2026-09-10
-
和铂医药:超长效靶向TSLP抗体哮喘二期临床取得阳性结果,三期临床已启动
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
动脉网-最新2026-09-09
-
药明康德2026-09-09
-
一度医药2026-09-08
-
阿斯利康中国2026-09-08
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-09-26
-
2026-09-26
-
2026-09-26
-
摩熵咨询 20 8
-
摩熵咨询 20 11
-
摩熵咨询 34 56
-
颁布机构:国家药品监督管理局 2026-09-10
-
颁布机构:四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构:国家医保局 2026-07-31
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-09-26
-
2026-09-26
-
2026-09-26
-
摩熵咨询 35 71
-
摩熵咨询 28 60
-
摩熵咨询 34 42
-
颁布机构:国家市场监督管理总局 2026-09-18
-
颁布机构:国家市场监督管理总局 2026-09-17
-
颁布机构:国家市场监督管理总局 2026-08-10
